A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive Interventions: Drug: budesonide/formoterol; Drug: albuterol/salbutamol; Drug: FF/UMEC/VI; Drug: Placebo to match budesonide/formoterol; Drug: tiotropium; Drug: Placebo to match FF/UMEC/VI; Drug: placebo to match tiotropium; Device: ELLIPTA; Device: MDI; Device: Han diHaler Sponsors: GlaxoSmithKline; Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Albuterol | Chronic Obstructive Pulmonary | Flonase | Proair HFA | Spiriva | Study | Symbicort | Tiotropium | Ventolin